Friday, July 10, 2026

pharma · Pancreatic Cancer

Zhejiang Provincial People's

Zhejiang Provincial People's is a pharma organization headquartered in CN. Primary therapeutic focus areas include Pancreatic Cancer. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s)

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
1
Patents
0
Clinical program

Pucotenlimab

Phase 2 · mab · Pancreatic Cancer

Pucotenlimab for Pancreatic Cancer is a Phase 2 program (mab) at Zhejiang Provincial People's Hospital with 1 ClinicalTrials.gov record(s).

Internal code Pucotenlimab in PDAC

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Zhejiang Provincial People's Hospital
Phase
Phase 2
Modality
mab
Indication
Pancreatic Cancer
Status
active
Trials
1

Clinical trials